Acute Radiation Syndrome
SNBL USA is in a unique position to perform ARS studies, from demonstration of efficacy in representative animal models, to pivotal nonclinical studies under the FDA’s Animal Efficacy Rule.
We are proud of SNBL’s long history of excellence and leadership across our multiple product and service offerings; but more importantly, we benchmark our true success by what we achieve for our customers today and what we do to enable a better future for patients and their families tomorrow.Read More
SNBL USA is committed to providing clients with quality you expect with your preclinical needs. We are committed to providing service you trust with the turnaround you need.
As a drug class, Nucleic Acid-based Therapeutics represents a diverse spectrum of chemistry, constructs, and delivery options.
Blending our strengths, SNBL USA’s laboratory services division represents a powerful resource to extend discovery and development capabilities while still providing superior, individualized service to each client.
Methods for the Implantation and Maintenance of Separate Intrathecal Catheters for Dose Administration and CSF Sampling in Cynomolgus Monkeys N. Lalayeva1, N. Bailey1, G. De Los Santos1, K. Crowder1S, Glaza1, J. Morris1, R. Nagata2 Intrathecal implantation of catheters equipped with subcutaneous access ports provides the means for repeated access to cerebrospinal fluid (CSF) in the intrathecal (IT) space around the spinal cord, without the need for chemical sedation. Factors, such as catheter position or location in the IT space, can influence long-term patency and post surgical...Read More
Everett, WA – February 12, 2015 – SNBL USA, the experts in primate research, today announced the appointment of Tina Rogers, PhD, MBA as the director of Safety Assessment. In this position Dr. Rogers will assume responsibility for all facets of the Safety Assessment department. She will manage day-to-day operations of the department to ensure continued operational and scientific excellence and work directly with the executive management team to formulate and direct current and long-range strategic plans, objectives and policies to support sponsors with the highest level of compliance...Read More
SNBL USA is pleased to announce Keiko Bucher has joined SNBL USA as a senior manager for the newly created group, Resource Optimization and Client Project Management. In this position Bucher is charged to evaluate, update and streamline internal process strategies in order to optimize the full study life cycle experience and ensure SNBL USA provides clients with the quality they expect, the service they trust and the turnaround they need. Bucher brings more than 18 years of experience in the CRO industry to SNBL USA. She is well-versed in many areas of the drug development process and has a...Read More